A new publication on etelcalcetide appeared in Kidney International on August 1, 2026. The paper is titled "The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor-cAMP activation."
Etelcalcetide is an approved compound. This entry reflects only that the publication has been listed in the journal, with the title as its stated subject matter.
No findings, outcomes, or efficacy data from the study are included here beyond the publication title itself. Readers interested in the full study details should consult the journal listing directly for the complete content and methodology.
For general background on etelcalcetide, readers can consult the compound overview for additional context.